Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5318)
All Articles published online
|
Publishing Process of This Article
|
Sep 14, 2014 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Aoki H, Nosho K, Igarashi H, Ito M, Mitsuhashi K, Naito T, Yamamoto E, Tanuma T, Nomura M, Maguchi H, Shinohara T, Suzuki H, Yamamoto H, Shinomura Y. MicroRNA-31 expression in colorectal serrated pathway progression. World J Gastroenterol 2014; 20(34): 12346-12349 [PMID: 25232271 DOI: 10.3748/wjg.v20.i34.12346] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i34/12346.htm |
| Number | Citing Articles |
| 1 |
Katsuhiko Nosho, Yasutaka Sukawa, Yasushi Adachi, Miki Ito, Kei Mitsuhashi, Hiroyoshi Kurihara, Shinichi Kanno, Itaru Yamamoto, Keisuke Ishigami, Hisayoshi Igarashi, Reo Maruyama, Kohzoh Imai, Hiroyuki Yamamoto, Yasuhisa Shinomura. Association of <i>Fusobacterium nucleatum</i> with immunity and molecular alterations in colorectal cancer. World Journal of Gastroenterology 2016; 22(2): 557-566 doi: 10.3748/wjg.v22.i2.557
|
| 2 |
Zheli Li, Zhi Zhao, Gang Zhang, Yufeng Liu, Shaohua Zheng. LncRNA MEG3 inhibits the proliferation and migration abilities of colorectal cancer cells by competitively suppressing MiR-31 and reducing the binding of MiR-31 to target gene SFRP1. Aging 2023; doi: 10.18632/aging.205274
|
| 3 |
Oscar Murcia, Miriam Juárez, Eva Hernández-Illán, Cecilia Egoavil, Mar Giner-Calabuig, María Rodríguez-Soler, Rodrigo Jover. Serrated colorectal cancer: Molecular classification, prognosis, and response to chemotherapy. World Journal of Gastroenterology 2016; 22(13): 3516-3530 doi: 10.3748/wjg.v22.i13.3516
|
| 4 |
Milena Peruhova, Monika Peshevska-Sekulovska, Boris Krastev, Gabriela Panayotova, Viktoriya Georgieva, Rossitza Konakchieva, Georgi Nikolaev, Tsvetelina Veselinova Velikova. What could microRNA expression tell us more about colorectal serrated pathway carcinogenesis?. World Journal of Gastroenterology 2020; 26(42): 6556-6571 doi: 10.3748/wjg.v26.i42.6556
|
| 5 |
Fatima De Palma, Valeria D’Argenio, Jonathan Pol, Guido Kroemer, Maria Maiuri, Francesco Salvatore. The Molecular Hallmarks of the Serrated Pathway in Colorectal Cancer. Cancers 2019; 11(7): 1017 doi: 10.3390/cancers11071017
|
| 6 |
Marco Bocchetti, Maria Grazia Ferraro, Filippo Ricciardiello, Alessandro Ottaiano, Amalia Luce, Alessia Maria Cossu, Marianna Scrima, Wing-Yan Leung, Marianna Abate, Paola Stiuso, Michele Caraglia, Silvia Zappavigna, Tung On Yau. The Role of microRNAs in Development of Colitis-Associated Colorectal Cancer. International Journal of Molecular Sciences 2021; 22(8): 3967 doi: 10.3390/ijms22083967
|
| 7 |
Hiroyoshi Kurihara, Reo Maruyama, Kazuya Ishiguro, Shinichi Kanno, Itaru Yamamoto, Keisuke Ishigami, Kei Mitsuhashi, Hisayoshi Igarashi, Miki Ito, Tokuma Tanuma, Yasutaka Sukawa, Kenji Okita, Tadashi Hasegawa, Kohzoh Imai, Hiroyuki Yamamoto, Yasuhisa Shinomura, Katsuhiko Nosho. The relationship between EZH2 expression and microRNA-31 in colorectal cancer and the role in evolution of the serrated pathway. Oncotarget 2016; 7(11): 12704 doi: 10.18632/oncotarget.7260
|